BACKGROUND: Stenting for symptomatic intracranial atherosclerotic disease is a
therapeutic option in patients in whom medical therapy fails. OBJECTIVE: To determine the …

Background—Everolimus-eluting bioresorbable vascular scaffolds have been developed to
improve late outcomes after coronary interventions. However, recent registries raised …

Percutaneous coronary intervention in the setting of acute myocardial infarction is known to
predict stent thrombosis (ST). This study aims to compare the ST rates across different …

Background Drug-eluting stents (DES) are considered the therapy of choice in ST-segment
elevation myocardial infarction (STEMI); however, a low persistent rate of revascularizations …

Objective The objective of this study was to determine the pathologic features of venous in-
stent stenosis over time occurring in bare metal stents. Methods Endovascular biopsy …

Objective—Although coronary perivascular adipose tissue (PVAT) may play important roles
as a source of inflammation, the association of coronary PVAT inflammation and coronary …

Background: Application of drug-coated balloons (DCBs) is popular for the treatment of
percutaneous coronary intervention (PCI). A new DCB has been designed as ultrasound …

Percutaneous coronary interventions (PCI), including balloon angioplasty and implantation
of both bare metal and drug eluting coronary stents, are associated with risk of restenosis …

The Ultimaster coronary stent system (Terumo Corporation, Tokyo, Japan) represents a new
iteration in drug-eluting stent (DES) technology that has recently received the Conformité …

Objectives: The purpose of this study was to evaluate the frequency and predictors of stent
thrombosis (ST) after stenting for ST-segment elevation myocardial infarction (STEMI) …